Jingsong Zhang

Generating author description...

All published works

Action	Title	Year	Authors
+	Supplemental Information from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Data from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Supplemental Information from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S1 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S1 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics	2024	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S1 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Data from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S1 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Data from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S1 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S1 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Data from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+ PDF Chat	Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers	2023	Jad Chahoud Alexander R.A. Anderson Jingsong Zhang Joel S. Brown Robert A. Gatenby
+ PDF Chat	Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics	2023	Jill Gallaher Maximilian Strobl Jeffrey West Robert A. Gatenby Jingsong Zhang Mark Robertson‐Tessi Alexander R.A. Anderson
+	Abstract 852: Predicting progression in metastatic castrate-sensitive prostate cancer by coupling PSA and testosterone dynamics to a mechanistic mathematical model	2023	Jill Gallaher Maximilian Strobl Jeffrey West Mark Robertson‐Tessi Robert A. Gatenby Jingsong Zhang Alexander R.A. Anderson
+	Data from Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy	2023	Jeffrey B. West Mina N. Dinh Joel S. Brown Jingsong Zhang Alexander R.A. Anderson Robert A. Gatenby
+	Data from Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy	2023	Jeffrey B. West Mina N. Dinh Joel S. Brown Jingsong Zhang Alexander R.A. Anderson Robert A. Gatenby
+	Data from Towards Multidrug Adaptive Therapy	2023	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+	Supplementary Data from Towards Multidrug Adaptive Therapy	2023	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+	Supplementary Data from Towards Multidrug Adaptive Therapy	2023	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+	Data from Towards Multidrug Adaptive Therapy	2023	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+ PDF Chat	The sum and the parts: dynamics of multiple and individual metastases during adaptive therapy	2022	Jill Gallaher Maximilian Strobl Jeffrey West Jingsong Zhang Robert A. Gatenby Mark Robertson‐Tessi Alexander R.A. Anderson
+	Abstract CT159: A phase 2a evolutionarily informed, mathematically guided adaptive abiraterone trial in metastatic castrate resistant prostate cancer	2022	Jingsong Zhang Joel S. Brown Jessica J. Cunningham Evan Adler Robert A. Gatenby
+	Author response: Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes	2022	Jingsong Zhang Jessica J. Cunningham Joel S. Brown Robert A. Gatenby
+	Towards Multidrug Adaptive Therapy	2020	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+	Abstract SY38-02: Personalized adaptive therapy for metastatic cancer: An integrated approach	2019	Eunjung Kim Jill Gallaher Mark Robertson‐Tessi Inna Smalley Robert A. Gatenby Keiran S.M. Smalley Jingsong Zhang Zeynep Eroglu Alexander R.A. Anderson
+	Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer (mCRPC): Updated analysis of the adaptive abiraterone (abi) study (NCT02415621).	2019	Jingsong Zhang Mayer Fishman Joel S. Brown Robert A. Gatenby
+ PDF Chat	Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy	2019	Jeffrey West Mina N. Dinh Joel S. Brown Jingsong Zhang Alexander R.A. Anderson Robert A. Gatenby
+ PDF Chat	Towards multi-drug adaptive therapy	2018	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+ PDF Chat	Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model	2017	You Li Joel S. Brown Frank Thuijsman Jessica J. Cunningham Robert A. Gatenby Jingsong Zhang Kateřina Staňková
+	Abstract 5562: Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer: a pilot multidisciplinary study	2017	Jingsong Zhang Jessica J. Cunningham Joel S. Brown Robert A. Gatenby

Common Coauthors

Coauthor	Papers Together
Robert A. Gatenby	55
Alexander R.A. Anderson	50
Jeffrey West	43
Jill Gallaher	40
Mark Robertson‐Tessi	40
Maximilian Strobl	39
Joel S. Brown	13
Paul K. Newton	6
You Li	6
Jessica J. Cunningham	4
Jeffrey West	3
Mina N. Dinh	3
Jeffrey B. West	2
Joel S. Brown	2
Kateřina Staňková	1
Zeynep Eroglu	1
Inna Smalley	1
Jad Chahoud	1
Frank Thuijsman	1
Evan Adler	1
You Li	1
Mayer Fishman	1
Eunjung Kim	1
Keiran S.M. Smalley	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Adaptive Therapy	2009	Robert A. Gatenby Ariosto S. Silva Robert J. Gillies B. Roy Frieden	7
+ PDF Chat	Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model	2017	You Li Joel S. Brown Frank Thuijsman Jessica J. Cunningham Robert A. Gatenby Jingsong Zhang Kateřina Staňková	5
+	Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment	2018	Jeffrey West Yongqian Ma Paul K. Newton	4
+ PDF Chat	How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient	2017	Elsa Hansen Robert J. Woods Andrew F. Read	4
+ PDF Chat	Optimizing Cancer Treatment Using Game Theory	2018	Kateřina Staňková Joel S. Brown William S. Dalton Robert A. Gatenby	4
+ PDF Chat	Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy	2019	Jeffrey West Mina N. Dinh Joel S. Brown Jingsong Zhang Alexander R.A. Anderson Robert A. Gatenby	4
+	Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2018	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson	4
+ PDF Chat	Studying the emergence of invasiveness in tumours using game theory	2008	David Basanta Haralampos Hatzikirou Andreas Deutsch	3
+ PDF Chat	Turnover Modulates the Need for a Cost of Resistance in Adaptive Therapy	2020	Maximilian Strobl Jeffrey West Yannick Viossat Mehdi Damaghi Mark Robertson‐Tessi Joel S. Brown Robert A. Gatenby Philip K. Maini Alexander R.A. Anderson	3
+	Cancer as an evolutionary and ecological process	2006	Lauren M.F. Merlo John W. Pepper Brian J. Reid Carlo C. Maley	3
+ PDF Chat	Exploiting ecological principles to better understand cancer progression and treatment	2013	David Basanta Alexander R.A. Anderson	3
+ PDF Chat	The value of monitoring to control evolving populations	2015	Andrej Fischer Ignacio Vázquez-Garćıa Ville Mustonen	3
+	A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.	1979	Goldie Jh Coldman Aj	2
+	Computer simulation of a breast cancer metastasis model	1997	Michael Retsky Romano Demicheli Douglas E. Swartzendruber Paul D. Bame Robert H. Wardwell Gianni Bonadonna John F. Speer Pinuccia Valagussa	2
+	The Clonal Evolution of Tumor Cell Populations	1976	Peter C. Nowell̀	2
+	A Dynamical Model for the Growth and Size Distribution of Multiple Metastatic Tumors	2000	Koichi Iwata K. Kawasaki Nanako Shigesada	2
+ PDF Chat	Systemic Cancer Progression and Tumor Dormancy: Mathematical Models Meet Single Cell Genomics	2006	Christoph A. Klein D. Hölzel	2
+ PDF Chat	Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind	2012	David Basanta Robert A. Gatenby Alexander R.A. Anderson	2
+ PDF Chat	Cancer treatment as a game: integrating evolutionary game theory into the optimal control of chemotherapy	2012	Paul A. Orlando Robert A. Gatenby Joel S. Brown	2
+ PDF Chat	Estimating Dose Painting Effects in Radiotherapy: A Mathematical Model	2014	Juan Carlos López Alfonso Nick Jagiella L. A. Núñez Miguel A. Herrero Dirk Drasdo	2
+	Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation	2015	Rebecca H. Chisholm Tommaso Lorenzi Alexander Lorz Annette K. Larsen Luís Almeida Alexandre E. Escargueil Jean Clairambault	2
+	Evolutionary dynamics of carcinogenesis and why targeted therapy does not work	2012	Robert J. Gillies Daniel Verduzco Robert A. Gatenby	2
+	Micrometastases formation: A probabilistic model	1977	Lance A. Liotta Charles DeLisi Gerald M. Saidel Jerome Kleinerman	2
+ PDF Chat	Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition	2015	Aaron Goldman Biswanath Majumder Andrew Dhawan Sudharshan Ravi David Goldman Mohammad Kohandel Pradip K. Majumder Shiladitya Sengupta	2
+ PDF Chat	Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies	2009	Jasmine Foo Franziska Michor	2
+ PDF Chat	Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer	2012	Robert A. Beckman Gunter S. Schemmann Chen-Hsiang Yeang	2
+ PDF Chat	Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)	2006	Maha Hussain Catherine M. Tangen Celestia S. Higano Paul F. Schelhammer James R. Faulkner E. David Crawford George Wilding A. Akdaş Eric J. Small Bryan Donnelly	2
+	Evolutionary dynamics of cancer in response to targeted combination therapy	2013	Ivana Božić Johannes G. Reiter Benjamin Allen Tibor Antal Krishnendu Chatterjee Preya Shah Yo Sup Moon Amin Yaqubie Nicole Kelly Dung T. Le	2
+ PDF Chat	How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine	2010	Marco Gerlinger Charles Swanton	2
+ PDF Chat	Evolution of cooperation among tumor cells	2006	Robert Axelrod David Axelrod Kenneth J. Pienta	2
+ PDF Chat	Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion	2008	David Basanta Matthias Simon Haralampos Hatzikirou Andreas Deutsch	2
+ PDF Chat	Bridging Population and Tissue Scale Tumor Dynamics: A New Paradigm for Understanding Differences in Tumor Growth and Metastatic Disease	2014	Jill Gallaher ARAVIND BABU Sylvia K. Plevritis Alexander R.A. Anderson	2
+	Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer	2012	Ariosto S. Silva Yoonseok Kam Zayar P. Khin Susan Minton Robert J. Gillies Robert A. Gatenby	2
+	Evolutionary Theory of Cancer	2009	Camille Stephan‐Otto Attolini Franziska Michor	2
+ PDF Chat	Cancer Prevention Strategies That Address the Evolutionary Dynamics of Neoplastic Cells: Simulating Benign Cell Boosters and Selection for Chemosensitivity	2004	Carlo C. Maley Brian J. Reid Stephanie Forrest	2
+	Ecological Therapy for Cancer: Defining Tumors Using an Ecosystem Paradigm Suggests New Opportunities for Novel Cancer Treatments	2008	Kenneth J. Pienta Natalie McGregor Robert Axelrod David Axelrod	2
+ PDF Chat	Application of Evolutionary Principles to Cancer Therapy	2015	Pedro M. Enríquez‐Navas Jonathan W. Wojtkowiak Robert A. Gatenby	2
+	Stochastic Model of Metastases Formation	1976	Lance A. Liotta Gerald M. Saidel Jerome Kleinerman	2
+ PDF Chat	Classifying the evolutionary and ecological features of neoplasms	2017	Carlo C. Maley Athena Aktipis Trevor A. Graham Andrea Sottoriva Amy M. Boddy Michalina Janiszewska Ariosto S. Silva Marco Gerlinger Yinyin Yuan Kenneth J. Pienta	2
+ PDF Chat	A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth	2013	Jacob G. Scott David Basanta Alexander R.A. Anderson Philip Gerlee	2
+ PDF Chat	Spatial competition constrains resistance to targeted cancer therapy	2017	Katarina Bačević Robert Noble Ahmed Soffar Orchid Ammar Benjamin Boszonyik Susana Prieto Charles Vincent Michael Hochberg Liliana Krasińska Daniel Fisher	2
+ PDF Chat	Size Matters: Metastatic Cluster Size and Stromal Recruitment in the Establishment of Successful Prostate Cancer to Bone Metastases	2018	Arturo Araujo Leah M. Cook Conor C. Lynch David Basanta	2
+ PDF Chat	The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory	2019	Jeffrey West Mark Robertson‐Tessi Kimberly A. Luddy Derek S. Park Drew F. K. Williamson Cathal Harmon Hung T. Khong Joel S. Brown Alexander R.A. Anderson	2
+ PDF Chat	Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS)	2018	Ella Y. Tyuryumina Alexey Neznanov	2
+	Nonlinear adaptive control of competitive release and chemotherapeutic resistance	2019	Paul K. Newton Yuechao Ma	2
+	Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer	2019	Artem Kaznatcheev Jeffrey Peacock David Basanta Andriy Marusyk Jacob G. Scott	2
+ PDF Chat	A Mathematical Framework for Modelling the Metastatic Spread of Cancer	2019	Linnea C. Franssen Tommaso Lorenzi A.E.F. Burgess Mark A. J. Chaplain	2
+ PDF Chat	Inferring rates of metastatic dissemination using stochastic network models	2019	Philip Gerlee Mia Johansson	2
+ PDF Chat	Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers	2013	Sébastien Benzekry Philip Hahnfeldt	2
+	A mathematical model for the immune-mediated theory of metastasis	2019	Adam Rhodes Thomas Hillen	2